Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Titan‑1™ platform enables high-resolution identification of bacterial strains from complex samples using a patented amplicon sequencing approach combined with proprietary AI analytics. It has been validated through pharma/academic collaborations for biomarker discovery and patient care applications such as GutID™, an at-home gut microbiome test launched in partnership with PacBio. No clinical trial results are reported as the company does not develop therapeutics directly.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intus Biosciences.